The workflow
First to test
Clinicians use new tools in real care before anyone else. You can tell a product that fits clinical reality from one that only works in a demo.
For physicians · Healthcare, AI & life sciences
Deal flow validated by domain experts in healthcare, life sciences, and AI.
Investing for physicians usually means index funds, real estate and the practice itself. The LSM Group adds a different option: an invitation-only syndicate for accredited investors that brings early-stage healthcare, AI and life sciences companies to the people who understand them best. Membership is free, and you decide company by company whether to participate.
Free to join. No commitment.

Why now
Healthcare technology is tested in clinics before it is tested in markets. Physicians are the first to see whether a diagnostic is reliable, whether an AI tool saves time or adds clicks, and whether patients keep using a therapy after the first month.
Generalist investors try to model that from the outside. Physician investors have already watched it happen at the bedside.

The workflow
First to test
Clinicians use new tools in real care before anyone else. You can tell a product that fits clinical reality from one that only works in a demo.
The regulation
Approval to adoption
You understand why clearance, reimbursement and adoption take as long as they do, and what slows a company down along the way.
The patients
After month one
You see which problems are worth solving, and whether patients keep using a therapy once the novelty wears off.
That clinical judgment often decides whether a health technology company succeeds, yet the people who hold it are rarely in the room when these companies raise capital — a gap The LSM Group was built to close.
Your clinical judgment already shapes which companies succeed. Now it can shape where you invest.
Free to join. No commitment.
Membership
Most physician investing follows the same pattern: retirement accounts, public markets, real estate and the practice. Membership adds a different kind of investing for doctors: access to private healthcare companies, at no cost and with no obligation to invest. For women physicians, it is a natural starting point for investing for women in early-stage healthcare: your clinical judgment counts from the first presentation, whether or not you have invested in private companies before.
Each company that reaches you has passed a domain expert panel first. Companies that fail that review never reach the network.
The expert’s written assessment travels with the opportunity, so you are reading an evaluation rather than building one.
Founders present to the network and take questions directly. Domain experts are in the room and ask the hard ones.
How we read healthcare, AI and life sciences each quarter. No pitches.
The differentiator
Each company is matched to a domain expert in its exact category: an operator who has run a diagnostics business, a clinician who has carried a therapeutic through approval, a specialist who has deployed AI in a regulated setting. That expert writes a Signal Report, and the network reads it alongside the opportunity.
Signal Reports are shared openly with the network, so each expert’s judgment is on the record.
Process

Companies are sourced through the network, not from inbound decks.
A specialist in that exact category assesses the company and writes the Signal Report.
We map who realistically acquires a company like this, and at what stage, before anyone invests.
We confirm whether credible investors are positioned to fund the next round.
The company presents to the network and takes questions. You receive the Signal Report at the same time.
Answer yes or no after the presentation. Opting in brings you the written terms, not a commitment.
If you invest, reporting on your companies sits in one place on the investment platform.
What the network includes
Membership is not a mailing list. Here is what a typical cycle looks like.
One to two times a month, members are invited to a live company presentation. You get the date in advance and attend the ones that interest you.
Before or during the presentation you receive the expert’s written assessment of the company.
After the presentation we ask every member for a yes or a no. Saying no takes one click and needs no explanation.
Members who say yes receive the details by email: the pitch deck, the investor memo and what the company is raising. You confirm your accredited investor status once.
If you invest, subscription documents, company reporting and tax forms sit in one secure portal.
Free to join. No commitment.
Why you
01
You see which devices actually get used, which workflows waste an hour a day, and which therapies patients abandon. Generalist investors model that from the outside. Members with deep expertise may be invited onto the domain expert panel for companies in their field.
02
Most physician wealth sits in the practice, public markets and real estate, all moving on cycles you do not control. Private healthcare companies sit in a different part of the market, and you choose each position individually.
03
Members review revenue-generating companies, specialty pharmaceutical assets with validated clinical data, and applied AI in regulated environments — sourced through relationships. Membership opens that door, and it is free.
Thesis

Founder-led · Expert-validated

Two decades in healthcare. Trained as a biomedical engineer. Built diagnostic laboratories. Founded and exited multiple healthcare companies across genomics, longevity, remote patient monitoring, digital musculoskeletal care, telomere science, and metabolic medicine.
The LSM Group co-invests alongside members in the deals it brings to the network.
Free to join. No commitment.
Terms
Cost to join the network: $0.
The terms below apply only when you choose to participate in an investment.
Fees apply per investment and are disclosed in full in the offering documents before you commit any capital.
No. If you never participate in an investment, it costs you nothing. Fees apply only to capital you choose to invest and are disclosed in full in the offering documents.
Apply anyway. You can review companies for as long as you like before participating in anything.
You receive the opportunity, read the Signal Report, attend the preview if you want to, and decide. Passing takes no time at all.
Free to join. No commitment.
Apply
Applying costs nothing and commits you to nothing. Applications are reviewed personally and we respond within five business days.
Membership is free. Fees apply only to capital you choose to invest and are disclosed in full in the offering documents.
Private investments are illiquid, involve a high degree of risk, and may result in the total loss of invested capital.
Questions
An accredited investor is a person the SEC considers financially able to take on the risk of private investments: for example, someone with income above $200,000 in each of the past two years ($300,000 with a spouse or partner) and the same expected this year, a net worth over $1 million excluding their primary home, or a Series 7, 65 or 82 license in good standing. The LSM Group network is open to accredited investors, and because the SEC can update these thresholds, the application always carries the current definition.
This page is for informational purposes only. It is not investment, tax or legal advice, and it is not an offer to sell or a solicitation of an offer to buy any security. Any offering is made only to accredited investors through definitive offering documents. Private investments are illiquid, involve a high degree of risk, and may result in the total loss of invested capital. Past performance does not indicate future results.